Ad5-yCD/mutTKSR39rep-hIL12

BIOLOGICAL2 trials

Sponsors

Henry Ford Health System

Conditions

Metastatic Pancreatic CancerProstate Cancer

Phase 1

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

CompletedNCT02555397

Henry Ford Health SystemProstate Cancer

Start: 2015-08-31End: 2024-01-22Updated: 2024-10-10

Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer

CompletedNCT03281382

Henry Ford Health SystemMetastatic Pancreatic Cancer

Start: 2017-07-01End: 2019-05-28Updated: 2022-03-02

Related Papers

A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma

PLoS ONE2023-09-1517 citations